Related Experiment Video
Updated: Sep 24, 2025
In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
Published on: August 9, 2017
Stem Cell Differentiation into Cardiomyocytes: Current Methods and Emerging Approaches
Elham Afjeh-Dana1, Parvaneh Naserzadeh2, Elham Moradi1,3
1Radiation Biology Research Centre, Iran University of Medical Sciences, Tehran, Iran.
Insights
Stem cell therapies offer a promising alternative for treating cardiovascular diseases (CVDs) when traditional treatments fail. Research focuses on generating mature, functional cardiomyocytes from stem cells (SCs) for heart repair, overcoming challenges like immune rejection.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Background:
- Cardiovascular diseases (CVDs) are a leading cause of global mortality and disability, with limited success in treating myocardial necrosis via conventional pharmacological methods.
- Current treatments for CVDs face significant challenges, particularly in addressing myocardial necrosis, highlighting the need for innovative therapeutic strategies.
Purpose of the Study:
- To explore the potential of stem cells (SCs) as a promising therapeutic approach for cardiovascular diseases (CVDs).
- To review methods for generating mature and functional cardiomyocytes from SCs for heart repair applications.
- To discuss the challenges and limitations associated with SC-based therapies for CVDs.
Main Methods:
- Discussion of various stem cell types suitable for cardiovascular applications.
- Review of commonly employed methods for cardiomyocyte generation, including embryoid body techniques, co-culture, mechanical stimulation, and electrical stimulation.
- Analysis of the advantages and limitations of each method in the context of SC-based CVD treatment.
Main Results:
- Stem cell-based therapies present a viable alternative to pharmacological treatments for CVDs, particularly for myocardial necrosis.
- Generating scalable, medical-grade cardiomyocytes with mature structures and functions is crucial for effective heart repair.
- Identified challenges include immune rejection, arrhythmogenesis, tumorigenesis, and graft cell death.
Conclusions:
- Stem cell differentiation into cardiomyocytes holds significant promise for treating cardiovascular diseases.
- Further research and development are needed to overcome existing challenges and optimize SC-based therapies for clinical application.
- Optimizing cardiomyocyte generation and addressing safety concerns are key to realizing the full potential of SCs in cardiovascular repair.
Abstract:
Cardiovascular diseases (CVDs) are globally known to be important causes of mortality and disabilities. Common treatment strategies for CVDs, such as pharmacological therapeutics impose serious challenges due to the failure of treatments for myocardial necrosis. By contrast, stem cells (SCs) based therapies are seen to be promising approaches to CVDs treatment. In such approaches, cardiomyocytes are differentiated from SCs. To fulfill SCs complete potential, the method should be appointed to generate cardiomyocytes with more mature structure and well-functioning operations. For heart repairing applications, a greatly scalable and medical-grade cardiomyocyte generation must be used. Nonetheless, there are some challenges such as immune rejection, arrhythmogenesis, tumorigenesis, and graft cell death potential. Herein, we discuss the types of potential SCs, and commonly used methods including embryoid bodies related techniques, co-culture, mechanical stimulation, and electrical stimulation and their applications, advantages and limitations in this field. An estimated 17.9 million people died from CVDs in 2019, representing 32 % of all global deaths. Of these deaths, 85 % were due to heart attack and stroke.
